The capsules utilize a gastric-resistant (enteric-coated) shell designed to survive the acidic stomach environment and dissolve in the higher pH conditions of the small intestine
Irregular dosing produces irregular results
WADA Prohibition The World Anti-Doping Agency explicitly prohibits AOD-9604 for competitive athletes: Listed under Section S0 (Non-Approved Substances) and S2.2.3 (Growth Hormone Fragments) Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions (TUEs) available Detection methods developed and implemented in anti-doping laboratories worldwide WADAs 2013 statement clarified that AOD-9604 is a substance still under pre-clinical and clinical development and has not been approved for therapeutic use by any government health authority in the world. Research Classification: AOD-9604 is available only for laboratory research use
International delivery: Countries we currently deliver to include: Australia, Austria, Bahrain, Belgium, Bulgaria, Canada, China, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Guernsey, Hong Kong SAR China, Hungary, Ireland, India, Isle of Man, Italy, Japan, Jersey, Latvia, Lithuania, Luxembourg, Malta, Malaysia, Netherlands, New Zealand, Norway, Oman, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, Sweden, Switzerland, Taiwan, United Arab Emirates
Conclusion Both TB-500 and BPC-157 have earned attention in the performance and recovery space for their regenerative potential, yet they serve different purposes
